Mr. Healy can turn the most complex CNS-centered trials into something that runs smoothly. With deep expertise across clinical operations, project management and delivery, and pharmacovigilance, he’s led and supported Phase 2-4 studies from kickoff to conclusion, both domestic and worldwide. His work has spanned indications, including Alzheimer’s Disease, Late-Life Depression, and Traumatic Brain Injury, among others. Both strategic and grounded, Mr. Healy is known for keeping project teams focused, timelines tight, and making even the toughest studies look easy. Mr. Healy is the steady force that can keep studies moving while maintaining quality and consistency for sponsors.

After more than two decades at Rho, Ms. Kopetskie knows that behind every strong clinical trial is an even stronger dataset to support the study’s findings. Her background spans everything from protocol development, analysis of clinical data, writing and reviewing statistical reports, and more. Her therapeutic experiences include CNS, infectious disease, transplantation, and additional indications. As the VP of Global Biometrics, Ms. Kopetskie manages a high-performing team of statisticians and programmers—she doesn’t just lead the numbers, but also the people behind them. With her sharp eye and calming force, she can help project teams turn complex data into knowledge.